JYOTHYLABNSEJyothy Labs Limited· Personal CareCriticalNegative
Announced Sat, 9 May · 15:23 IST

Jyothy Labs Limited has informed the Exchange regarding Outcome of Board Meeting held on May 09, 2026.

Deal CancelledStrategic Transactions View source PDF

JYOTHYLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-12.6%1-day move
₹261.00
prior close
₹242.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.9+1.5+1.2-2.7-12.6-14.8-15.5-15.9-17.6-20.0-23.4-23.6-22.9
Up moveDown movePending
AI summary

Jyothy Labs has announced that Henkel AG & Co. KGaA has decided not to renew the Pril brand license agreement beyond May 31, 2026. The original license and technology agreements were signed on May 31, 2011, covering manufacturing, distribution, marketing and sale of Pril and Fa brands. The company was in discussions with Henkel regarding renewal and other options, but these have concluded with no possibility of renewal. The board met on May 9, 2026, to evaluate the situation. The financial impact of losing the Pril license is currently under evaluation. The company states it is exploring all available options and will disclose material developments promptly.

Likely market impact

Loss of the Pril brand license could materially impact Jyothy Labs' revenue and product portfolio, given Pril is a significant consumer brand. The stock is likely to face negative sentiment until the financial impact is assessed and alternative strategies are disclosed.